Navigation Links
Launch of New, Prestigious Infertility and Gynaecology Research GrAnt (FRIGGA)
Date:2/13/2008

PARSIPPANY, N.J., Feb. 13 /PRNewswire/ -- Ferring Pharmaceuticals has launched the first Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) for fundamental fertility and gynaecology research. This is an international, themed, biennial initiative open to individual researchers or research units/departments with the first awarded research projects to be completed by January 2010.

Professor Paul Devroey, Free University Brussels, will lead the international expert judging panel for FRIGGA. Two grants to the value of euros 50,000 each will be awarded with the announcement of first recipients of the awards at the European Society of Human Reproduction and Embryology (ESHRE) congress in Barcelona (6 - 9 July 2008). The deadline for the submission of grant applications is 30 April 2008.

The award is named after Frigga, the goddess of fertility, motherhood, love, family and home from Scandinavian mythology. This name encapsulates both the objective of infertility research and treatment -- parenthood -- and echoes the company's Scandinavian roots. The theme for the 2008 award is fundamental research leading to an increased understanding of the role of human chorionic gonadotrophin (hCG) in assisted reproduction.

Mr. Michel Pettigrew, Chief Operating Officer at Ferring said, "We are committed to taking the lead in the field of assisted reproductive technologies (ART) and the launch of FRIGGA reflects this commitment. We look forward to innovative research carried out through the FRIGGA award that will increase our understanding of infertility and that in the future will help infertile couples around the world achieve their goal."

In announcing the theme of the 2008 award, Paul Devroey, comments "We have made great progress in the treatment of infertility in what is quite a short period of time for medicine. If, however, we are to meet the growing needs for treatment and the growing expectation of treatment standards, we need to prog
'/>"/>

SOURCE Ferring Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
3. BioSpace and BayBio Launch 11th Edition of Biotech Bay(TM) Hotbed Map Campaign
4. Novozymes Launches Enzyme to Reduce Acrylamide in Food
5. Enova Medical Launches Exos Corporation
6. Nitec Pharma AG Announces Appointments of CEO & CFO in Preparation for Launch of Lodotra(R)
7. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
8. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
9. Concuity Announces the Launch of Its New Fully Accessible Website - Concuity.Com
10. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
11. Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... Agritech Limited (NASDAQ GS: SEED) (" Origin ", or the ... China , today announced that the Company ... 30, 2014, before the market opens on Thursday, January 8, ... January 8, 2015, at 8:00 a.m. ET / 9:00 p.m. ... To participate in the call, please dial +1-888-346-8982 in ...
(Date:12/13/2014)... December 12, 2014 The DNA ... in 2013, and is expected to grow at ... , Browse through the TOC of the DNA ... trends and segments, with help of various tables ... global DNA Microarray market consists of instrument, consumables, ...
(Date:12/13/2014)... -- Vermillion, Inc. (NasdaqCM: VRML), a bio-analytical solutions company focused on ... G. H. Jordan , Ph.D., and David R. ... the total number of directors to eight, seven of ... , Chairman, President, and Chief Executive Officer of Vermillion, ... of Veronica and David to our board of directors.  ...
(Date:12/12/2014)... Yonkers, NY (PRWEB) December 11, 2014 ... ® bushing materials for pumps and process equipment, has ... Mid-West United States and Ontario, Canada. Staller holds a ... years experience in the industrial market place, much of ... be based out of his Michigan office. , ...
Breaking Biology Technology:Origin Agritech Limited to Announce Fiscal 2014 Annual Financial Results on January 8th, 2015 2Origin Agritech Limited to Announce Fiscal 2014 Annual Financial Results on January 8th, 2015 3DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 2DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 3DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 4Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 2Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 3Kirk Staller Joins Graphite Metallizing Corporation 2
... Pharmion - ... - Sirtuins implicated in tumor ... combination epigenetic therapies, BOULDER, Colo. and MONTREAL, Aug. 20 ... MYG) today announced a,research collaboration for the development of novel ...
... 900 attendees from 47 countries convene in Seattle for AIDS ... ... global researchers,clinicians, and specialists convene this week for the AIDS Vaccine ... Vaccine,2000 Conference in Paris, this event has emerged as the premier ...
... OMAHA, Neb., Aug. 14 Transgenomic, Inc. (the,"Company") (OTC ... ended June 30, 2007. The Company,s financial results are,presented ... The Company reported a net profit of $0.2 ... 2007 as compared to a net loss of $0.4 ...
Cached Biology Technology:Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 2Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 3Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 4Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 5Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 6Global Experts Explore Entire Spectrum of Aids Vaccine Development 2Transgenomic, Inc. Reports Second Quarter 2007 Results 2Transgenomic, Inc. Reports Second Quarter 2007 Results 3Transgenomic, Inc. Reports Second Quarter 2007 Results 4Transgenomic, Inc. Reports Second Quarter 2007 Results 5Transgenomic, Inc. Reports Second Quarter 2007 Results 6Transgenomic, Inc. Reports Second Quarter 2007 Results 7Transgenomic, Inc. Reports Second Quarter 2007 Results 8
(Date:11/21/2014)... November 18, 2014 According to ... by Systems (Video, RFID, Access Control, Intrusion Detection, Parking ... Banks, Government), Component Service Geography - Global Forecasts to ... is projected to be around $25 Billion in 2014 ... growing at a CAGR of 8.69%. Browse ...
(Date:11/21/2014)... 20, 2014   Atmel® Corporation (NASDAQ: ... and touch technology solutions, today launched the industry,s first ... the widest V cc range from 1.7V to ... faster I 2 C bus communication speeds, and are ... making them ideal for consumer, industrial, computer, and medical ...
(Date:11/18/2014)... YORK , Nov. 18, 2014   ... identity authentication solutions, and MorphoTrust USA ... and services, today announced a strategic partnership to ... enterprise, motor vehicle administration (MVA), airport screening and ... in identity-related solutions, MorphoTrust serves consumers through a ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... USB port into a sheet of paper, and turning it ... ideas like this have researchers at North Carolina State University ... like woven cotton or even a sheet of paper. ... If we can find a way to apply them to ...
... the current issue of Global Change Biology Bioenergy ... candidates as second-generation energy sources because they have genetic ... Sustainable, large-scale bioenergy production requires domestication that develops crops ... degraded land. Yan and coauthors collected ...
... have a weakening in the quality of their bone structure ... plenty of weight-bearing exercise, a new study finds. The results ... Meeting in Boston. "Given the high number of young ... that up to 24% of young female athletes may lose ...
Cached Biology News:Research examines how to apply conductive nanocoatings to textiles 2Athletic girls more likely to have impaired bone structure if menstrual cycle stops 2
Goat anti-VAV2 Class: Antibody Product Group: Miscellaneous Antibody...
Rabbit polyclonal to M13 Bacteriophage Coat Proteins ( Abpromise for all tested applications)....
E2F-5...
Rabbit polyclonal to Flagellin ( Abpromise for all tested applications). Antigen: Synthetic peptide from the flagellin C terminal domain of Burkholderia pseudomallei....
Biology Products: